Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14168784 | 0.87 | LMNA (0.43) | ALDH1A1TP53CYP3A4MGLLLMNA | |
| SCHEMBL11239739 | 0.82 | LMNA (0.66) | ALDH1A1MGLLLMNAPOLB | |
| SCHEMBL12284997 | 0.81 | LMNA (0.59) | ALDH1A1MGLLLMNAPOLB | |
| SCHEMBL14168893 | 0.80 | LMNA (0.36) | ALDH1A1LMNAPOLB | |
| SCHEMBL14169000 | 0.79 | L3MBTL1 (0.36) | ALDH1A1MGLLLMNAPOLB | |
| SCHEMBL29678737 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TP53CYP3A4MGLLLMNA | |
| SCHEMBL2031900 | 0.77 | CA2 (0.47) | ALDH1A1LMNAPOLB | |
| SCHEMBL1700804 | 0.77 | ALDH1A1 (0.59) | ALDH1A1TP53CYP3A4MGLLLMNA | |
| SCHEMBL471906 | 0.77 | ALDH1A1 (0.55) | ALDH1A1TP53CYP3A4MGLLLMNA | |
| SCHEMBL18938837 | 0.76 | LMNA (0.43) | ALDH1A1CYP3A4LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3558936-B1 | PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFIN PRECURSORS | HENKEL AG & CO KGAA (DE) | 2024-08-14 | — | — | EP | disclosed |
| EP-3558935-B1 | PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS | HENKEL AG & CO KGAA (DE) | 2023-11-29 | — | — | EP | disclosed |
| CN-110114337-B | Method for preparing electron-deficient olefins | 汉高股份有限及两合公司 | 2023-05-30 | — | — | CN | disclosed |
| US-11639330-B2 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | SHOWA DENKO K.K. (JP) | 2023-05-02 | — | — | US | disclosed |
| CN-110121494-B | Method for producing cyanoacrylic esters | 汉高股份有限及两合公司 | 2023-02-17 | — | — | CN | disclosed |
| EP-3558933-B1 | PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFIN PRECURSORS | HENKEL AG & CO KGAA (DE) | 2022-11-23 | — | — | EP | disclosed |
| EP-3558937-B1 | PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS | Henkel IP & Holding GmbH (DE) | 2022-05-11 | — | — | EP | disclosed |
| US-10913707-B2 | Process for preparing electron deficient olefins | Henkel IP & Holding GmbH (DE) | 2021-02-09 | — | — | US | disclosed |
| US-10913708-B2 | Process for preparing electron deficient olefin precursors | Henkel IP & Holding GmbH (DE) | 2021-02-09 | — | — | US | disclosed |
| US-10889542-B2 | Process for preparing electron deficient olefins | Henkel IP & Holding GmbH (DE) | 2021-01-12 | — | — | US | disclosed |
| WO-2018114460-A1 | PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS | Henkel IP & Holding GmbH (DE) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018114464-A1 | PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS | Henkel IP & Holding GmbH (DE) | 2018-06-28 | — | — | WO | disclosed |
| EP-2217557-B1 | ACTIVATED METHYLENE REAGENTS | Henkel IP & Holding GmbH (DE) | 2018-01-24 | — | — | EP | disclosed |
| CN-101896454-B | Activated methylene reagents and curable compositions prepared therefrom | LOCTITE R & D LTD | 2013-07-10 | — | — | CN | disclosed |
| US-8481755-B2 | Activated methylene reagents and curable compositions prepared therefrom | HENKEL IRELAND LTD. (DE) | 2013-07-09 | — | — | US | disclosed |
| US-8399698-B1 | Substituted activated methylene reagents and methods of using such reagents to form electron deficient olefins | HENKEL IRELAND LIMITED (DE) | 2013-03-19 | — | — | US | disclosed |
| CN-101896454-A | Activated methylene reagents and curable compositions prepared therefrom | LOCTITE R & D LTD | 2010-11-24 | — | — | CN | disclosed |
| EP-2217557-A2 | ACTIVATED METHYLENE REAGENTS AND CURABLE COMPOSITIONS PREPARED THEREFROM | Loctite (R & D) Limited (IE) | 2010-08-18 | — | — | EP | disclosed |
| US-20100199888-A1 | ACTIVATED METHYLENE REAGENTS AND CURABLE COMPOSITIONS PREPARED THEREFROM | LOCTITE (R&D) LIMITED (IE) | 2010-08-12 | — | — | US | disclosed |
| WO-2009053482-A2 | ACTIVATED METHYLENE REAGENTS AND CURABLE COMPOSITIONS PREPARED THEREFROM | LOCTITE (R & D) LIMITED (IE) | 2009-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11639330-B2 | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | AFF1, PHOSPHO1, CHRM1 | ALDH1A1 3194/4885TP53 4006/4885CYP3A4 2259/4885 |
| US-20100199888-A1 | ACTIVATED METHYLENE REAGENTS AND CURABLE COMPOSITIONS PREPARED THEREFROM | NOTUM, WASF2, BHMT2 | ALDH1A1 876/4885TP53 3491/4885CYP3A4 1926/4885 |
| US-10913708-B2 | Process for preparing electron deficient olefin precursors | COASY, ETFA, PCCA | ALDH1A1 607/4885TP53 4669/4885CYP3A4 136/4885 |
| US-10889542-B2 | Process for preparing electron deficient olefins | COASY, ACSL4, PCCA | ALDH1A1 1475/4885TP53 4734/4885CYP3A4 227/4885 |
| US-10913707-B2 | Process for preparing electron deficient olefins | PCCA, ACSL4, COASY | ALDH1A1 1279/4885TP53 4714/4885CYP3A4 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.